{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:17:31Z","timestamp":1791231451301,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":2478,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jmoldx.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T13:46:18Z","timestamp":1356615978000},"page":"220-226","source":"Crossref","is-referenced-by-count":202,"title":["Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of Melanoma"],"prefix":"10.1016","volume":"15","author":[{"given":"Wesley O.","family":"Greaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur P.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedia A.","family":"Barkoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Galbincea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth D.","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajyalakshmi","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2012.10.002_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1479-5876-8-67","article-title":"Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032","volume":"8","author":"Rubinstein","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Flaherty","year":"2010","journal-title":"N Engl J Med"},{"issue":"15 Suppl","key":"10.1016\/j.jmoldx.2012.10.002_bib4","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1200\/jco.2011.29.15_suppl.8509","article-title":"BRIM-2: An open-label, multicenter phase II study of vemurafenib in previously treated patients with BRAF V600E mutation-positive metastatic melanoma (abstract)","volume":"29","author":"Ribas","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib5","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib6","doi-asserted-by":"crossref","first-page":"14903","DOI":"10.1073\/pnas.1008990107","article-title":"The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner","volume":"107","author":"Joseph","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PDM.0b013e31823b216f","article-title":"Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma","volume":"21","author":"Halait","year":"2012","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib8","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.5858\/arpa.2011-0505-OA","article-title":"Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed paraffin-embedded tissue specimens of malignant melanoma","volume":"136","author":"Anderson","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/PAT.0b013e3283532565","article-title":"Incidence of BRAF p.Val600Glu and p.Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region","volume":"44","author":"Amanuel","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib10","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1309\/AJCPL0OPXI9LZITV","article-title":"Rapid detection and quantitation of BRAF mutations in hairy cell leukemia using a sensitive pyrosequencing assay","volume":"138","author":"Verma","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1146\/annurev.pathol.3.121806.151541","article-title":"Molecular pathogenesis of cutaneous melanocytic neoplasms","volume":"4","author":"Ibrahim","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.0022-202x.2001.01601.x","article-title":"Analysis of N- and K-ras mutations in the distinctive tumor progression phases of melanoma","volume":"117","author":"Demunter","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0022-202X.2004.22243.x","article-title":"Genetic interaction between NRAS and BRAF mutations and PTEN\/MMAC1 inactivation in melanoma","volume":"122","author":"Tsao","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol Oncol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","article-title":"Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis","volume":"164","author":"Lee","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrclinonc.2011.69","article-title":"BRAF targeted therapy changes the treatment paradigm in melanoma","volume":"8","author":"Ribas","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib18","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib19","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/1078-0432.CCR-1169-3","article-title":"Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas","volume":"10","author":"Shinozaki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2353\/jmoldx.2007.060191","article-title":"Application of a BRAF pyrosequencing assay for mutation detection and copy number analysis in malignant melanoma","volume":"9","author":"Spittle","year":"2007","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.5858\/2007-131-1361-BMIMLA","article-title":"BRAF mutations in melanocytic lesions and papillary thyroid carcinoma samples identified using melting curve analysis of polymerase chain reaction products","volume":"131","author":"Hay","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2012.10.002_bib23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.humpath.2005.03.015","article-title":"Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis","volume":"36","author":"Willmore-Payne","year":"2005","journal-title":"Hum Pathol"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157812003108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157812003108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T18:39:05Z","timestamp":1643999945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157812003108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1525157812003108"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2012.10.002","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}